Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors

Overview of attention for article published in Frontiers in Pharmacology, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,643 followers.

RT @FrontPharmacol: New Research: Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors #…

17 Jul 2023

Reply Repost Favourite

New Research: Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors #pharmacology https://t.co/GcfNsuttNZ

17 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.